Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Phase 3 CRUISE-1 trial to treat iron deficiency anemia in dialysis patients begins - NephrOnline |
 |
 |
|
NephrOnline Renal biopharmaceutical company Rockwell Medical announced that it has started enrollment in its Phase 3 CRUISE-1 clinical study of Soluble Ferric Pyrophosphate (SFP), designed to treat iron deficiency anemia in hemodialysis patients receiving ... Rockwell Medical Starts Pivotal Phase III Clinical Study for Treatment of Iron |
